• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.48% Nasdaq Down1.25%

    Tekmira Pharmaceuticals Corp (TKMR)

    -NasdaqCM
    14.17 Down 0.44(3.01%) 11:28AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 14,953   15,465   14,105  
    Cost of Revenue -   -   -  
    Gross Profit 14,953   15,465   14,105  
    Operating Expenses
    Research Development38,713  21,458  18,043  
    Selling General and Administrative8,683  5,546  8,141  
    Non Recurring -   -   -  
    Others529  613  866  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (32,972) (12,152) (12,945)
    Income from Continuing Operations
    Total Other Income/Expenses Net(5,865)(1,911)42,556  
    Earnings Before Interest And Taxes(38,837)(14,063)29,611  
    Interest Expense -   -   -  
    Income Before Tax(38,837)(14,063)29,611  
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(38,837)(14,063)29,611  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (38,837) (14,063) 29,611  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (38,837) (14,063) 29,611  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.